Clinical Trial Update: Plaque Psoriasis Efficacy and Safety With Secukinumab [Phase 3]

View source ↗

Summary

Phase 3 trial results for secukinumab in plaque psoriasis have been completed with posted results in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Secukinumab (secukinumab)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Plaque Psoriasis | Phase 3 | Status: COMPLETED | Results posted: 2019-05-13